The Use of Fluconazole Prophylaxis in Patients with Chemotherapy-Induced Neutropenia

References

• Walsh T. J., et al. Detection of circulating candida enolase by immunoassay in patients with cancer and invasive candidiasis. N. End. J. Med. 1981; 324: 1026
   Web of Science ®Google Scholar
• Thaler M., Pastakia B., Shawker T. H., O'Leary T., Pizzo P. A. Hapatic candidiasis in cancer patients; the evolving picture of the syndrome. Ann. Intern. Med. 1988; 108: 88–100
   PubMed Web of Science ®Google Scholar
• Wingard J. R., Merz W. G., Saral R. Candida tropicalis a major pathogen in immuno-compromised patients. Ann. Intern. Med. 1979; 91: 539–543
   PubMed Web of Science ®Google Scholar
• Horn R., Wong B., Kiehn T. E., Armstrong D. Fungemia in a cancer hospital: changing frequency, earlier onset, and results of therapy. Rev Infect. Dis. 1985; 7: 646–55
   PubMedGoogle Scholar
• Karp J. E., Burch P. A., Merz W. G. An approach to intensive antileukemia therapy in patients with previous invasive aspergillosis. Am. J. Med. 1988; 85: 203–6
   PubMed Web of Science ®Google Scholar
• Saral R. Candida and aspergillus infections in immunocompromised patients: an overview. Rev. Infect. Dis. 1991; 13: 487–92
   PubMedGoogle Scholar
• Goodman J. L., Winston D. J., Greenfield R. A. A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation. N. Engl. J. Med. 1992; 326: 845–851
   PubMed Web of Science ®Google Scholar
• Pizzo P. A., Robichaud R. N., Gill F. A., et al. Empiric antibiotic and antifungal therapy for cancer patients with prolonged fever and granulo-cytopenia. Am. J. Med. 1982; 72: 101–110
   PubMed Web of Science ®Google Scholar
• EORTC International Antimocrobial Therapy Cooperative Group. Empiric antifungal therapy in febrile granulocy-topenic patients. Am. J. Med. 1989; 86: 668–672
   PubMed Web of Science ®Google Scholar
• Dick J. D., Merz W. G., Saral R. Incidence of polyene-resistant yeasts recovered from clinical specimens. Antimicrob. Agents Chemother. 1980; 18: 158–63
   PubMed Web of Science ®Google Scholar
• Jones P. G., Kauffman C. A., McAuliffe L. S., Liepman M. K., Bergman A. G. Efficacy of ketoconazole vs nystatin in prevention of fungal infections in neutropenic patients. Arch. Intern. Med. 1984; 144: 549–551
   PubMed Web of Science ®Google Scholar
• Estey E., Maksymuik A., Smith T., et al. Infection prophylaxis in acute leukemia: comparative effectiveness of sulfamethoxazole and trimethoprim, ketoconazole, and a combination of the two. Arch. Inlern. Med. 1984; 144: 1562–1568
   PubMed Web of Science ®Google Scholar
• Shepp D. H., Klosterman A., Siegel M. S., Myers J. D. Comparative trial of ketoconazole and nystatin for prevention of fungal infection in neutropenic patients treated with a protective environment. Infect. Dis. 1985; 152: 1257–1263
   Google Scholar
• Walsh T. J., Rubin M., Hathorn J., et al. Amphotericin B vs high-dose ketoconazole for empirical antifungal therapy among febrile, granulocytopenic cancer patients. Arch. Intern. Med. 1991; 151: 765–770
   PubMed Web of Science ®Google Scholar
• Wingard J. R., Vaughan W. P., Braine H. G., et al. Prevention of fungal sepsis in patients with prolonged neutropenia: A randomized double-blind, placebo-controlled trial of intravenous miconazole. Am. J. Med. 1987; 83: 1103–1110
   PubMed Web of Science ®Google Scholar
• Wiley J. M., Smith N., Leventhal B. G., et al. lnvasive fungal disease in pediatric acute leukemia patients with fever and neutropenia during induction chemotherapy: a multivariate analysis of risk factors. J. Clin. Oncol. 1990; 8: 280–6
   PubMed Web of Science ®Google Scholar
• Robinson P. A., Knirsch A. K., Joseph J. A. Fluconazole for life threatening fungal infections in patients who cannot be treated with conventional antifungal agents. Rev. Infect. Dis. 1990; 12(suppl 3)S349–S363
   PubMedGoogle Scholar
• Kauffman C. A., Bradley S. F., Ross S. C., Weber D. R. Hepatosplenic Candidiasis: successful treatment with fluconazole. Am. J. Med. 1991; 91: 137–141
   PubMed Web of Science ®Google Scholar
• Anaissie E., Bodey G. P., Kantarjian H., et al. Fluconazole therapy for chronic disseminated candidiasis in patients with leukemia and prior amphotericin B therapy. Am. J. Med. 1991; 91: 142–150
   PubMed Web of Science ®Google Scholar
• Samonis G. S., Rolston K., Karl C., Miller P., Bodey G. P. Prophylaxis of Oropharyngeal Candidiasis with fluconazole. Rev. Infect. Dis. 1990; 12: S369–373
   PubMedGoogle Scholar
• Brammer K. W. Management of fungal infection in neutropenic patients with fluconazole. Hematology & Blood Transfusions 1990; 33: 546–50
   PubMedGoogle Scholar
• Rozenberg-Arska M., Dekker A. W., Branger J., Verhoef J. A randomized study to compare oral fluconazole to amphotericin B in the prevention of fungal infections in patients with acute leukemia. J. Antimicrob. Chemoth. 1991; 27: 369–376
   PubMed Web of Science ®Google Scholar
• Meunier F., Aoun M., Janssens M., Dekoster C., Paesmans M. Chemoprophylaxis of fungal infections in granulocytopenic patients using fluconazole vs oral amphotericin B. Drug. Invest. 1991; 3(4)258–265
   Google Scholar
• Winston D. J., Islam Z., Beull D. N. Fluconazole prophylaxis of fungal infections in acute leukemia patients: results of a placebo-controlled double-blind, multi center trial. Program and Abstracts of the 31st International Conference on Antimicrobial Agents and Chemotherapy, Chicago, Sept. 29-Oct. 2, 1991. American Society of Microbiology, Washington DC 1991; 99, Acute Leukemia Study Group, Abstract # 6.
   Google Scholar
• Kruger H. U., Schuler U., Zimmerman R., Ehninger G. No severe drug interaction of fluconazole, a triazole antifungal agent, with cyclosporin. Bone Marrow Transplant 1988; 3(Suppl 1)271
   Google Scholar
• Walsh T. J., Aoki S., Mechinaud F., et al. Effects of preventive, early, and late antifungal chemotherapy with fluconazole in different granulocytopenic models of experimental disseminated Candidiasis. J. Infici. Dis. 1990; 161: 755–760
   PubMed Web of Science ®Google Scholar
• Filler S. G., Crislip M. A., Mayer C. L., Edwards J. E. Comparison of fluconazole and amphotericin B for treatment of disseminated Candidiasis and endophthalmitis in rabbits. Antimicrob. Agents Chemother. 1991; 35: 288–292
   PubMed Web of Science ®Google Scholar
• Patterson T. F., George D., Miniter P., Andreole V. T. The role of fluconazole in the early treatment and prophylaxis of experimental invasive Aspergillosis. J. Infect. Dis. 1991; 164: 575–80
   Google Scholar
• Wingard J. R., Merz W. G., Rinaldi M. G., Johnson T. R., Karp J. E., Saral R. Increase in Candida krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole. N. Engl. J. Med. 1991; 325: 1274–1277
   PubMed Web of Science ®Google Scholar
• Casasnovas R. O., Caillot D., Solary E., et al. Prophylactic fluconazole and Candida krusei infections. N. Engl. J. Med. 1992; 326: 891–892
   PubMed Web of Science ®Google Scholar
• Soutar R. L. Fluconazole or amphotericin B for cadidosis in neutropenic patients. Lancet 1991; 337: 181
   PubMed Web of Science ®Google Scholar
• Persons D. A., Laughlin M., Tanner D., Perfect J., Gockerman J. P., Hathorn J. W. Fluconazole and Candida krusei fungemia. N. Engl. Med. J. 1991; 325: 1315
   PubMed Web of Science ®Google Scholar